Display options
Share it on

Int J Fertil Steril. 2016 Apr-Jun;10(1):79-86. doi: 10.22074/ijfs.2016.4772. Epub 2016 Apr 05.

Ethyl Pyruvate Ameliorates The Damage Induced by Cyclophosphamide on Adult Mice Testes.

International journal of fertility & sterility

Zahra Bakhtiary, Rasoul Shahrooz, Abbas Ahmadi, Farhad Soltanalinejad

Affiliations

  1. Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran.

PMID: 27123204 PMCID: PMC4845533 DOI: 10.22074/ijfs.2016.4772

Abstract

BACKGROUND: Cyclophosphamide (CP) is a chemotherapy drug which causes deleterious effects on testicular tissue and increases free radicals in the body. The aim of this study is to investigate the protective effects of ethyl pyruvate (EP) on testicular improvement in CP treated animals.

MATERIALS AND METHODS: In this experimental study, 15 male mice (6-8 weeks) were divided into 3 groups. The control group received normal saline (0.1 ml/day), intraperitoneal (IP), CP group received CP (15 mg/kg/week, IP), and the CP+EP group received EP (40 mg/kg/day, IP) plus CP. After 35 days, we assessed serum total antioxidant capacity (TAC) along with histomorphometric and histochemical analyses of the testicles.

RESULTS: The mean thickness of the germinal epithelium, diameter of seminiferous tubules, and the number of Leydig cells in the CP+EP group were higher than those of the CP group (P<0.05). The number of the mast cells in the CP+EP group significantly reduced compared with the CP group (P<0.05). Alkaline phosphatase (ALP), periodic acid-schiff (PAS) positive reactions and lipid granules in cytoplasm of the Leydig cells in the CP group increased compared with the other groups (P<0.05). TAC in the CP group significantly reduced compared with the other groups (P<0.05).

CONCLUSION: This study showed the ability of EP to reduce the destructive side effects of CP in the adult mice reproductive system.

Keywords: Cyclophosphamide; Ethyl Pyruvate; Testis

References

  1. Hum Pathol. 2004 Jan;35(1):34-42 - PubMed
  2. J Surg Res. 2009 May 15;153(2):302-9 - PubMed
  3. Asian J Androl. 2000 Sep;2(3):191-8 - PubMed
  4. J Clin Oncol. 1999 May;17(5):1493-8 - PubMed
  5. Asian J Androl. 2002 Sep;4(3):201-7 - PubMed
  6. Anim Reprod Sci. 2007 Feb;97(3-4):303-13 - PubMed
  7. J Pharmacol Exp Ther. 1970 Aug;174(2):206-10 - PubMed
  8. J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S486-94 - PubMed
  9. Curr Pharm Des. 1999 Aug;5(8):627-43 - PubMed
  10. Drug Chem Toxicol. 2002 Aug;25(3):281-92 - PubMed
  11. Reprod Toxicol. 2004 Dec;19(2):163-7 - PubMed
  12. Chem Biol Interact. 2002 Jan 22;139(1):79-95 - PubMed
  13. J Cardiovasc Pharmacol. 2000 Aug;36(2):182-7 - PubMed
  14. Biochem Pharmacol. 1992 Aug 18;44(4):747-53 - PubMed
  15. Reprod Toxicol. 2007 Nov-Dec;24(3-4):365-70 - PubMed
  16. Andrologia. 2007 Oct;39(5):185-9 - PubMed
  17. Methods Enzymol. 1999;299:15-27 - PubMed
  18. Am J Ind Med. 1983;4(1-2):149-61 - PubMed
  19. Hum Exp Toxicol. 2008 Jan;27(1):49-54 - PubMed
  20. Free Radic Res. 2002 Nov;36(11):1209-18 - PubMed
  21. Hum Exp Toxicol. 2001 Dec;20(12):643-50 - PubMed
  22. Endocrinol Metab Clin North Am. 1998 Dec;27(4):927-43 - PubMed
  23. Toxicology. 2006 Jan 5;217(1):71-8 - PubMed
  24. Exp Biol Med (Maywood). 2004 Mar;229(3):264-9 - PubMed
  25. Chem Biol Interact. 2004 Dec 30;151(1):13-9 - PubMed
  26. Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2623-9 - PubMed
  27. Toxicology. 2006 May 1;222(1-2):60-70 - PubMed
  28. Indian J Exp Biol. 1980 Sep;18(9):1001-4 - PubMed
  29. Biochem Biophys Res Commun. 1997 Jul 18;236(2):407-12 - PubMed
  30. Br J Cancer Suppl. 1986;7:89-101 - PubMed
  31. Neurosci Lett. 2003 Oct 30;350(3):173-7 - PubMed

Publication Types